4Filed Aug 25, 8:00 PM ET
NeurAxis (NRXS) CRO Thomas Carrico Exercises Options, Receives RSUs
$NRXS · Neuraxis, INCResearch Summary
AI-generated summary of this SEC filing
NeurAxis (NRXS) CRO Thomas Carrico Exercises Options, Receives RSUs
What Happened
- Carrico Thomas Joeseph (CRO, CCO, CPO) had stock-option/derivative activity and RSU awards on 2026-08-24. The Form 4 reports conversion of 306,236 derivative securities with one conversion shown at $6.94 per share for total reported proceeds of $2,125,278. The filing also shows grants/awards of 306,236 RSUs (which vested) and a separate grant/acquisition of 193,678 shares. The issuer withheld 112,558 shares to satisfy income tax withholding on vesting.
Key Details
- Transaction date(s): 2026-08-24; Form 4 filed 2026-08-26.
- Reported conversion: 306,236 derivative shares at $6.94 = $2,125,278 (per the filing). Another conversion entry shows N/A price/amount.
- Awards/grants: 306,236 RSUs granted and vested immediately; additional 193,678 shares reported as granted/acquired.
- Tax withholding: 112,558 shares were withheld by the issuer to satisfy income tax obligations upon vesting (Footnote F1).
- Footnote context: Options under a prior plan were canceled and replaced by an equivalent number of RSUs that vested immediately (Footnote F2).
- Shares owned after the reported transactions: not specified in the supplied summary — see the full Form 4 for post-transaction beneficial ownership.
- Filing timeliness: Form 4 lists the report period 8/24/2026 and was filed 8/26/2026.
Context
- These entries reflect awards/vestings and conversion of derivative securities (options-to-RSUs), not an open-market purchase. Withholding of shares for taxes and conversion/cancellation of legacy options in exchange for RSUs are common corporate compensation actions and do not, by themselves, indicate the insider's view on the stock. For full details and exact post-transaction holdings, consult the complete Form 4 (Accession 0001493152-26-040275).